Abiopharma

News list

Director ROSENSWEIG DANIEL 🟡 adjusted position in 1.4K shares (2 derivative) of ADOBE INC. (ADBE) Transaction Date: Apr 15, 2026 | Filing ID: 000089

Full text

News bot April 17, 2026, 8:36 p.m.
🔍 ROSENSWEIG DANIEL (Director)

Company: ADOBE INC. (ADBE)

Report Date: 2026-04-15
Transaction Summary:
- Total transactions: 4
- Derivative instruments: 2
- Holdings reported: 1
- Total shares acquired: 2,267
- Total shares sold: 900
- Total shares held: 14,028
Detailed Transactions and Holdings:
- Acquired 900 shares of Common Stock (Direct)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,906.00 | transaction_form_type: 4
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-15 | Code: H | nature_of_ownership: by trust | shares_owned_after: 14,028.00 | Footnotes: F1
- Sold 900 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F2
- Acquired 1,367 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,367.00 | transaction_form_type: 4 | Footnotes: F3, F3
Footnotes:
- F1: Includes 2,268 shares held by the Rosensweig 2012 Irrevocable Children's Trust dtd 11/6/2012, of which the reporting person is a trustee, and 11,760 shares held by the Rosensweig Family Revocable Trust dtd 3/12/2007, of which the reporting person is a trustee.
- F2: This restricted stock unit award vested in full on April 15, 2026.
- F3: Vests 100% on the day of the Issuer's next annual meeting of stockholders.